Aktienkurs
163,69
$
-81,96
33,36 %1 M.
-113,15
40,87 %6 M.
-74,28
31,21 %YTD
-4,74
2,81 %1 J.
+110,36
206,94 %3 J.
+138,71
555,28 %5 J.
+138,71
555,28 %10 J.
NYSE,
Schlusskurs Mo, 16.05.2022
Powered by
ISIN
US4577301090
Symbol
INSP
Index
Sektor
Industrie
Kennzahlen
| Marktkapitalisierung | 4,52 Mrd. USD |
| Enterprise Value | 4,35 Mrd. USD |
| EV/Sales (TTM) EV/Sales | 16,57 |
| KUV (TTM) KUV | 17,21 |
| KBV (TTM) KBV | 20,05 |
| Umsatzwachstum (TTM) Umsatzwachstum | 95,28 % |
| Umsatz (TTM) Umsatz | 262,42 Mio. USD |
| EBIT (Operatives Ergebnis TTM) EBIT | -40,22 Mio. USD |
| Free Cashflow (TTM) Free Cashflow | -27,03 Mio. USD |
Mehr anzeigen
Finanzdaten von Inspire Medical Systems, Inc.
| Mär. '22 |
+/-
%
|
||
| Umsatz | 262 262 |
95 %
95 %
|
|
| Bruttoertrag | 225 225 |
97 %
97 %
|
|
| EBITDA | -38 -38 |
29 %
29 %
|
EBIT (Operatives Ergebnis) EBIT | -40 -40 |
27 %
27 %
|
| Nettogewinn | -43 -43 |
26 %
26 %
|
|
Angaben in Millionen USD.
News
Seeking Alpha
5 Tage alt
|
Positiv
Inspire Medical Systems Priced Low In Past-Year Repeated Range
Medical equipment producers suffered demand constrictions as Covid-19 hospital capacity and personnel were conscripted to handle the pandemic. INSP stock recuperated from $50 to $250 in a year. Today's MM-hedging induced price range forecast sees a 23%+ gain from shared current market price depression to return to the $185 base of its prior-year range.
Medical equipment producers suffered demand constrictions as Covid-19 hospital capacity and personnel were conscripted to handle the pandemic. INSP stock recuperated from $50 to $250 in a year. Today's MM-hedging induced price range forecast sees a 23%+ gain from shared current market price depression to return to the $185 base of its prior-year range.
GlobeNewsWire
6 Tage alt
|
Neutral
Inspire Medical Systems, Inc. to Present at the USB Global Healthcare Conference 2022
MINNEAPOLIS, May 11, 2022 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire”), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will be presenting at the UBS Global Healthcare Conference on May 25, 2022 at the Lotte New York Palace in New York, New York.
MINNEAPOLIS, May 11, 2022 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire”), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will be presenting at the UBS Global Healthcare Conference on May 25, 2022 at the Lotte New York Palace in New York, New York.
Seeking Alpha
13 Tage alt
|
Neutral
Inspire Medical Systems, Inc. (INSP) CEO Timothy Herbert on Q1 2022 Results - Earnings Call Transcript
Inspire Medical Systems, Inc. (NYSE:INSP ) Q1 2022 Results Conference Call May 3, 2022 5:00 PM ET Company Participants Megan Rowekamp - Investor Relations Timothy Herbert - President and Chief Executive Officer Richard Buchholz - Chief Financial Officer Conference Call Participants Travis Steed - BofA Securities Robert Marcus - JPMorgan Chase Philip Coover - Goldman Sachs Group Danielle Antalffy - SVB Leerink Richard Newitter - Truist Securities Jonathan Block - Stifel, Nicolaus & Company Lei Huang - Wells Fargo Securities Adam Maeder - Piper Sandler & Co Michael Polark - Wolfe Research Suraj Kalia - Oppenheimer & Co Operator Good day and thank you for standing by. Welcome to the Inspire Medical Systems' Q1 2022 Financial Results and Business Update Conference Call.
Inspire Medical Systems, Inc. (NYSE:INSP ) Q1 2022 Results Conference Call May 3, 2022 5:00 PM ET Company Participants Megan Rowekamp - Investor Relations Timothy Herbert - President and Chief Executive Officer Richard Buchholz - Chief Financial Officer Conference Call Participants Travis Steed - BofA Securities Robert Marcus - JPMorgan Chase Philip Coover - Goldman Sachs Group Danielle Antalffy - SVB Leerink Richard Newitter - Truist Securities Jonathan Block - Stifel, Nicolaus & Company Lei Huang - Wells Fargo Securities Adam Maeder - Piper Sandler & Co Michael Polark - Wolfe Research Suraj Kalia - Oppenheimer & Co Operator Good day and thank you for standing by. Welcome to the Inspire Medical Systems' Q1 2022 Financial Results and Business Update Conference Call.
Firmenprofil
Inspire Medical Systems, Inc. beschäftigt sich mit der Entwicklung und Kommerzialisierung von minimal-invasiven Lösungen für Patienten mit obstruktiver Schlafapnoe. Es bietet die Inspire-Therapie an, die aus einer Fernbedienung und implantierbaren Komponenten besteht, zu denen eine Drucksensorleitung, ein Neurostimulator und eine Stimulationsleitung gehören. Das Unternehmen wurde im November 2007 von Timothy P. Herbert gegründet und hat seinen Hauptsitz in Golden Valley, MN.
| Hauptsitz | USA |
| CEO | Timothy Herbert |
| Mitarbeiter | 485 |
| Gegründet | 2007 |
| Webseite | www.inspiresleep.com |
aktien.guide Premium
Mit dem Premium Zugang erhältst Du sämtliche Funktionen von aktien.guide uneingeschränkt mit Realtime-Kursen für 6850 weltweite Aktien - auf komplett werbefreien Seiten.
* bei jährlicher Zahlung